ATE460668T1 - Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren - Google Patents

Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren

Info

Publication number
ATE460668T1
ATE460668T1 AT06739883T AT06739883T ATE460668T1 AT E460668 T1 ATE460668 T1 AT E460668T1 AT 06739883 T AT06739883 T AT 06739883T AT 06739883 T AT06739883 T AT 06739883T AT E460668 T1 ATE460668 T1 AT E460668T1
Authority
AT
Austria
Prior art keywords
quantification
breast cancer
vitamin receptors
predicting breast
cellular folate
Prior art date
Application number
AT06739883T
Other languages
German (de)
English (en)
Inventor
Philip Low
Lynn Hartmann
Christopher Leamon
Phil Ellis
Original Assignee
Purdue Research Foundation
Endocyte Inc
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation, Endocyte Inc, Mayo Foundation filed Critical Purdue Research Foundation
Application granted granted Critical
Publication of ATE460668T1 publication Critical patent/ATE460668T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT06739883T 2005-03-30 2006-03-30 Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren ATE460668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66643005P 2005-03-30 2005-03-30
PCT/US2006/011376 WO2006105141A1 (en) 2005-03-30 2006-03-30 Method for cancer prognosis using cellular folate vitamin receptor quantification

Publications (1)

Publication Number Publication Date
ATE460668T1 true ATE460668T1 (de) 2010-03-15

Family

ID=36754569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06739883T ATE460668T1 (de) 2005-03-30 2006-03-30 Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren

Country Status (10)

Country Link
US (1) US20090081710A1 (enExample)
EP (2) EP1864133B1 (enExample)
JP (1) JP2008537778A (enExample)
CN (1) CN101203759A (enExample)
AT (1) ATE460668T1 (enExample)
AU (1) AU2006230219A1 (enExample)
CA (1) CA2602585A1 (enExample)
DE (1) DE602006012816D1 (enExample)
RU (1) RU2007139912A (enExample)
WO (1) WO2006105141A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231868D1 (de) 2001-04-24 2009-05-20 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
JP4814520B2 (ja) 2002-05-15 2011-11-16 エンドサイト，インコーポレイテッド ビタミン−マイトマイシン結合体
EP2529758A3 (en) 2003-01-27 2013-01-02 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates
US20050232919A1 (en) 2004-02-12 2005-10-20 Morphotek, Inc. Monoclonal antibodies that specifically block biological activity of a tumor antigen
EP1789391B1 (en) 2004-07-23 2017-06-28 Endocyte, Inc. Bivalent linkers and conjugates thereof
CN101175757B (zh) 2005-03-16 2012-11-14 恩多塞特公司 蝶酸及其缀合物的合成和纯化
JP2009521206A (ja) 2005-04-22 2009-06-04 モルフォテック、インク． 免疫エフェクター活性を有する葉酸受容体アルファ陽性細胞に内部移行する抗体
JP5475992B2 (ja) 2005-08-19 2014-04-16 エンドサイト，インコーポレイテッド 多剤リガンド結合体
WO2008101231A2 (en) 2007-02-16 2008-08-21 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN101678124A (zh) 2007-03-14 2010-03-24 恩多塞特公司 结合配体连接的微管溶素递药缀合物
EP3569251A1 (en) 2007-06-25 2019-11-20 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CN101909441B (zh) 2007-10-25 2015-05-13 恩多塞特公司 微管蛋白抑制剂及其制备方法
CN102549434A (zh) * 2009-07-31 2012-07-04 恩多塞特公司 叶酸盐靶向的诊断和治疗
CN103037900B (zh) 2010-02-24 2016-04-06 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
RU2630608C2 (ru) * 2010-11-05 2017-09-11 Морфотек Инк. Рецептор фолиевой кислоты альфа в качестве диагностического и прогностического маркера злокачественных опухолей, экспрессирующих рецептор фолиевой кислоты альфа
EP2638395A4 (en) * 2010-11-12 2016-06-01 Endocyte Inc METHOD FOR TREATING CARCINOMA
CA2831426C (en) * 2011-04-01 2023-02-21 Immunogen, Inc. Methods for increasing efficacy of folr1 cancer therapy
PL2731972T3 (pl) 2011-07-15 2018-06-29 Eisai R&D Management Co., Ltd. Przeciwciała skierowane przeciwko receptorowi folianowemu alfa i ich zastosowania
WO2013126797A1 (en) 2012-02-24 2013-08-29 Purdue Research Foundation Cholecystokinin b receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
CN104755498B (zh) 2012-08-31 2019-06-18 伊缪诺金公司 用于检测叶酸受体1的诊断测定和试剂盒
CN102861020A (zh) * 2012-09-25 2013-01-09 上海交通大学医学院附属仁济医院 叶酸在制备预防大肠腺瘤初发药物中的应用
KR20150070318A (ko) 2012-10-16 2015-06-24 엔도사이트, 인코포레이티드 비천연 아미노산을 함유하는 약물 전달 컨쥬게이트 및 사용 방법
US20140154702A1 (en) * 2012-11-30 2014-06-05 Endocyte, Inc. Methods For Treating Cancer Using Combination Therapies
US9637547B2 (en) 2013-08-30 2017-05-02 Immunogen, Inc. Monoclonal antibodies for detection of folate receptor 1
SG10202102555TA (en) * 2013-10-08 2021-04-29 Immunogen Inc Anti-folr1 immunoconjugate dosing regimens
EP3071971B1 (en) 2013-11-19 2019-04-24 Purdue Research Foundation Patient selection method for inflammation
JP6246030B2 (ja) * 2014-03-12 2017-12-13 東芝メディカルシステムズ株式会社 病理染色装置及び病理染色方法
IL257531B2 (en) 2015-09-17 2023-04-01 Immunogen Inc Medicinal compositions containing anti-folr1 immunoconjugates
US11313868B2 (en) * 2016-06-14 2022-04-26 Board Of Regents, The University Of Texas System Methods of detecting anti-folic acid antibodies and uses thereof
CN106483282B (zh) * 2016-09-29 2018-08-31 北京世纪沃德生物科技有限公司 一种抗原稳定剂及其制备方法与应用
JP7072571B2 (ja) 2016-11-23 2022-05-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗葉酸受容体アルファ抗体およびその使用
CN117741149A (zh) * 2024-02-19 2024-03-22 卡秋(江苏)生物科技有限公司 一种用于卵巢癌细胞叶酸受体α的检测试剂盒及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989838A (en) 1992-03-11 1999-11-23 Institute Of Virology, Slovak Academy Of Sciences Immunological methods of detecting MN proteins and MN polypeptides
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US5846739A (en) * 1995-12-05 1998-12-08 Wisconsin Alumni Research Foundation Immunohistochemical detection assay for carcinoma proliferative status
US6358682B1 (en) 1998-01-26 2002-03-19 Ventana Medical Systems, Inc. Method and kit for the prognostication of breast cancer
CN102805868A (zh) 2000-03-31 2012-12-05 普渡研究基金会 用配体-免疫原缀合物治疗的方法
KR20040053136A (ko) 2001-09-28 2004-06-23 펄듀 리서치 파운데이션 리간드-면역원 공액체를 이용한 치료 방법
EP1496934A4 (en) 2002-04-19 2006-08-02 Endocyte Inc IMPROVED IMMUNOTHERAPY BY ADJUVANT
JP4814520B2 (ja) 2002-05-15 2011-11-16 エンドサイト，インコーポレイテッド ビタミン−マイトマイシン結合体
EP2529758A3 (en) 2003-01-27 2013-01-02 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates

Also Published As

Publication number Publication date
EP1864133A1 (en) 2007-12-12
US20090081710A1 (en) 2009-03-26
AU2006230219A1 (en) 2006-10-05
RU2007139912A (ru) 2009-05-10
CN101203759A (zh) 2008-06-18
EP1864133B1 (en) 2010-03-10
JP2008537778A (ja) 2008-09-25
DE602006012816D1 (de) 2010-04-22
WO2006105141A1 (en) 2006-10-05
CA2602585A1 (en) 2006-10-05
EP2199796A1 (en) 2010-06-23

Similar Documents

Publication Publication Date Title
ATE460668T1 (de) Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
NO20071309L (no) Fremgangsmate for ekspansjon
SG169361A1 (en) Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
EP1873925A4 (en) COMMUNICATION QUALITY DETERMINATION METHOD, MOBILE STATION, BASE STATION AND COMMUNICATION SYSTEM
ZA200610116B (en) Voltammetric systems for assaying biological analytes
BRPI0616862A2 (pt) Método e sistema para determinar uma transmissibilidade de reservatório de, pelo menos, uma camada de uma formação subterrânea, e, programa de computador
LT3421498T (lt) Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui
DE502005002345D1 (de) Verfahren zur einstellung von sitzkomponenten
EP2114241A4 (en) METHOD AND SYSTEM FOR PROVIDING ANALYTE MONITORING
EP1937143A4 (en) TECHNIQUES FOR ASSESSING URINARY INCONTINENCE AT THE EFFORT
ATE510439T1 (de) Verfahren und vorrichtung zum bestimmen, übermitteln und/oder verwenden von verzögerungsinformationen
ATE375518T1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
EP1917528A4 (en) BIOLOGICAL MARKERS AND METHODS FOR DETERMINING RECEPTIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS (EGFR)
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
EP2256497A4 (en) METHOD FOR QUANTIFYING SOLUBLE LR11
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis
NO20072293L (no) Lettvektsbyggeplate, samt fremgangsmate for tilvirkning av denne
DK1781321T3 (da) Fremgangsmåde til behandling af cancer, der omfatter en vegf-b-antagonist
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
EP1726358A4 (en) METHOD FOR FILLING A SOLID CATALYST
BRPI0920993A2 (pt) aparelho para instalar tampões de cimento de um poço, e método para implantar tampões de cimentação.
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
EP1796677A4 (en) PROCESS FOR ACTIVATION OF TRPV4 CHANNEL RECEPTORS BY AGONISTS
EP1862804A4 (en) METHOD FOR DIAGNOSIS OF PROSTATE CANCER

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties